The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Microtubules and resistance to tubulin-binding agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Conserved microtubule–actin interactions in cell movement and morphogenesis
Rodriguez, O. C., Schaefer, A. W., Mandato, C. A., Forscher, P., Bement, W. M., & Waterman-Storer, C. M. (2003) · Nature Cell Biology · doi:10.1038/ncb0703-599 · Cited by 844
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832
Dynamics and mechanics of the microtubule plus end
Howard, J., & Hyman, A. A. (2003) · Nature · doi:10.1038/nature01600 · Cited by 747
Structural basis for the regulation of tubulin by vinblastine
Gigant, B., Wang, C., Ravelli, R. B. G., Roussi, F., Steinmetz, M. O., Curmi, P. A., Sobel, A., & Knossow, M. (2005) · Nature · doi:10.1038/nature03566 · Cited by 734
Vakoc, B. J., Lanning, R. M., Tyrrell, J. A., Padera, T. P., Bartlett, L. A., Stylianopoulos, T., Munn, L. L., Tearney, G. J., Fukumura, D., Jain, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.1971 · Cited by 719
Post-translational modifications regulate microtubule function
Westermann, S., & Weber, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1260 · Cited by 717
Stuck in Division or Passing through
Rieder, C. L., & Maiato, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.002 · Cited by 657
Multiple Forms of Tubulin: Different Gene Products and Covalent Modifications
Ludueña, R. F. (1997) · International Review of Cytology · doi:10.1016/s0074-7696(08)62138-5 · Cited by 611
Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., & Horwitz, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119642 · Cited by 601
Self-citationVerhey, K. J., & Gaertig, J. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4633 · Cited by 558
Brito, D. A., & Rieder, C. L. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.043 · Cited by 539
Taxanes, microtubules and chemoresistant breast cancer
McGrogan, B. T., Gilmartin, B., Carney, D. N., & McCann, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.004 · Cited by 535
Perez, E. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0366 · Cited by 521
Hall, A. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9166-3 · Cited by 509
Tubulin modifications and their cellular functions
Hammond, J. W., Cai, D., & Verhey, K. J. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.11.010 · Cited by 509
Tubulin dynamics in cultured mammalian cells.
Saxton, W. M., Stemple, D. L., Leslie, R. J., Salmon, E. D., Zavortink, M., & McIntosh, J. R. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.6.2175 · Cited by 488
Thomas, E. S., Gomez, H. L., Li, R. K., Chung, H.-C., Fein, L. E., Chan, V. F., Jassem, J., Pivot, X. B., Klimovsky, J. V., de Mendoza, F. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6557 · Cited by 481
Microtubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
Microtubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
Thomas, E. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5019 · Cited by 428
The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography
Nettles, J. H., Li, H., Cornett, B., Krahn, J. M., Snyder, J. P., & Downing, K. H. (2004) · Science · doi:10.1126/science.1099190 · Cited by 421
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
Rouzier, R., Rajan, R., Wagner, P., Hess, K. R., Gold, D. L., Stec, J., Ayers, M., Ross, J. S., Zhang, P., Buchholz, T. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408974102 · Cited by 413
The role of stathmin in the regulation of the cell cycle
Rubin, C. I., & Atweh, G. F. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20187 · Cited by 408
Downing, K. H. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.89 · Cited by 382
Lim kinases, regulators of actin dynamics
Bernard, O. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.11.011 · Cited by 338
Rusan, N. M., Fagerstrom, C. J., Yvon, A.-M. C., & Wadsworth, P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.4.971 · Cited by 328
How do anti-mitotic drugs kill cancer cells?
Gascoigne, K. E., & Taylor, S. S. (2009) · Journal of Cell Science · doi:10.1242/jcs.039719 · Cited by 327
Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F. O., Ferrandina, G., et al. (2005) · PubMed · Cited by 323
Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K., & Richer, J. K. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1046 · Cited by 320
Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F. O., Ferrandina, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.298.11.1 · Cited by 303
Thomas, E., Tabernero, J., Fornier, M., Conté, P., Fumoleau, P., Lluch, A., Vahdat, L. T., Bunnell, C. A., Burris, H. A., Viens, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9102 · Cited by 290
Class III β‐tubulin in human development and cancer
Katsetos, C. D., Herman, M. M., & Mörk, S. J. (2003) · Cell Motility · doi:10.1002/cm.10116 · Cited by 282
Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
Sève, P., & Dumontet, C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70029-9 · Cited by 274
Kamath, K., Wilson, L., Cabral, F., & Jordan, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414477200 · Cited by 247
Dan, S., Tsunoda, T., Kitahara, O., et al. (2002) · PubMed · Cited by 246
Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Shi, J., Orth, J. D., & Mitchison, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6699 · Cited by 234
Ahmed, A. A., Mills, A. D., Ibrahim, A. E. K., Temple, J., Blenkiron, C., Vias, M., Massie, C. E., Iyer, N. G., McGeoch, A., Crawford, R., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.014 · Cited by 233
Wild-type p53 negatively regulates the expression of a microtubule-associated protein.
Murphy, M., Hinman, A., & Levine, A. J. (1996) · Genes & Development · doi:10.1101/gad.10.23.2971 · Cited by 221
Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer
Gan, P. P., Pasquier, E., & Kavallaris, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0509 · Cited by 221
Self-citationFerrandina, G., Zannoni, G. F., Martinelli, E., Paglia, A., Gallotta, V., Mozzetti, S., Scambia, G., & Ferlini, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2715 · Cited by 219
The importance of p53 location: nuclear or cytoplasmic zip code?
O’Brate, A., & Giannakakou, P. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.10.004 · Cited by 208
The role of β-tubulin isotypes in resistance to antimitotic drugs
Burkhart, C. A., Kavallaris, M., & Horwitz, S. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00022-6 · Cited by 198
Self-citationZhai, Y., Kronebusch, P. J., Simon, P. M., & Borisy, G. G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.1.201 · Cited by 198
Microtubules: A dynamic target in cancer therapy
Pasquier, E., & Kavallaris, M. (2008) · IUBMB Life · doi:10.1002/iub.25 · Cited by 195
Self-citationRosell, R., Scagliotti, G., Danenberg, K. D., Lord, R. V., Bepler, G., Novello, S., Cooc, J., Crinò, L., Sánchez, J. J., Taron, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206419 · Cited by 188
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
Kavallaris, M., Burkhart, C. A., & Horwitz, S. B. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690507 · Cited by 179
Self-citationBrito, D. A., Yang, Z., & Rieder, C. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805072 · Cited by 174
Martello, L. A., Verdier‐Pinard, P., Shen, H. J., He, L., Torres, K. E., Orr, G. A., & Horwitz, S. B. (2003) · PubMed · Cited by 158
Do β-tubulin mutations have a role in resistance to chemotherapy?
Berrieman, H. K., Lind, M., & Cawkwell, L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01411-1 · Cited by 153
Stathmin 1: a novel therapeutic target for anticancer activity
Rana, S. R., Maples, P. B., Senzer, N. N., & Nemunaitis, J. J. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.9.1461 · Cited by 149
Expression of class III β‐tubulin reduces microtubule assembly and confers resistance to paclitaxel
Hari, M., Yang, H., Zeng, C., Canizales, M., & Cabral, F. (2003) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.10132 · Cited by 148
Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins
Tommasi, S., Mangia, A., Lacalamita, R., Bellizzi, A., Fedele, V., Chiriatti, A., Thomssen, C., Kendzierski, N., Latorre, A. C., Lorusso, V., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22557 · Cited by 145
Self-citationLI, R., Moudgil, T. L., Ross, H. J., & Hu, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401554 · Cited by 139
Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential
Belletti, B., Nicoloso, M. S., Schiappacassi, M., Berton, S., Lovat, F., Wolf, K., Canzonieri, V., D’Andrea, S., Zucchetto, A., Friedl, P., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0894 · Cited by 131
Vansteenkiste, J., Lara, P. N., Chevalier, T. L., Breton, J.-L., Bonomi, P., Sandler, A. B., Socinski, M. A., Delbaldo, C., McHenry, B. M., Lebwohl, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7097 · Cited by 130
Heald, R., & Nogales, E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.1.3 · Cited by 128
Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
Raspaglio, G., Filippetti, F., Prislei, S., Penci, R., Maria, I. D., Cicchillitti, L., Mozzetti, S., Scambia, G., & Ferlini, C. (2007) · Gene · doi:10.1016/j.gene.2007.11.015 · Cited by 119
Hasegawa, S., Miyoshi, Y., Egawa, C., Ishitobi, M., Taguchi, T., Tamaki, Y., Monden, M., & Noguchi, S. (2003) · PubMed · Cited by 113
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
Baselga, J. M., Zambetti, M., Llombart‐Cussac, A., Manikhas, G., Kubista, E., Steger, G. G., Makhson, A. N., Tjulandin, S., Ludwig, H., Verrill, M. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2646 · Cited by 113
Hunt, J. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0999 · Cited by 112
Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies
Dumontet, C., Jordan, M. A., & Lee, F. Y. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0986 · Cited by 112
Alli, E., Yang, J., Ford, J. M., & Hait, W. N. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029702 · Cited by 100
Zhang, C. C., Yang, J., Bash-Babula, J., White, E., Murphy, M. E., Levine, A. J., & Hait, W. N. (1999) · PubMed · Cited by 100
Microtubules are stabilized in confluent epithelial cells but not in fibroblasts.
Pepperkok, R., Bré, M., Davoust, J. M., & Kreis, T. E. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.3003 · Cited by 100
Verrills, N. M., Walsh, B. J., Cobon, G. S., Hains, P. G., & Kavallaris, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303378200 · Cited by 95
Self-citationA Ubiquitous β-tubulin Disrupts Microtubule Assembly and Inhibits Cell Proliferation
Bhattacharya, R., & Cabral, F. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0060 · Cited by 95
Brito, D. A., & Rieder, C. L. (2008) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20316 · Cited by 93
Steen, J. A. J., Steen, H., Georgi, A. B., Parker, K. C., Springer, M., Kirchner, M., Hamprecht, F. A., & Kirschner, M. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709807104 · Cited by 88
Verrills, N. M., Liem, N. L. M., Liaw, T. Y. E., Hood, B. D., Lock, R. B., & Kavallaris, M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500417 · Cited by 87
Self-citationTubulin proteomics: Towards breaking the code
Verdier‐Pinard, P., Pasquier, E., Xiao, H., Burd, B., Villard, C., Lafitte, D., Miller, L. M., Angeletti, R. H., Horwitz, S. B., & Braguer, D. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.09.020 · Cited by 84
LIM Kinase 2 Is Widely Expressed in All Tissues
Acevedo, K. M., Moussi, N., Li, R., Soo, P., & Bernard, O. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6813.2006 · Cited by 82
Šale, S., Sung, R. K., Shen, P., Yu, K. M., Wang, Y. C., Durán, G. E., Kim, J.-H., Fojo, T., Oefner, P. J., & Sikic, B. I. (2002) · PubMed · Cited by 79
Su, D., Smith, S. M., Preti, M., Schwartz, P. E., Rutherford, T., Menato, G., Danese, S., Ma, S., Yu, H., & Katsaros, D. (2009) · Cancer · doi:10.1002/cncr.24282 · Cited by 77
Bernard-Marty, C., Treilleux, I., Dumontet, C., Cardoso, F., Fellous, A., Gancberg, D., Bissery, M.-C., Paesmans, M., Larsimont, D., Piccart, M. J., et al. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.037 · Cited by 77
Lee, K. M., Cao, D., Itami, A., Pour, P. M., Hruban, R. H., Maitra, A., & Ouellette, M. M. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02792.x · Cited by 75
Freedman, H., Huzil, J. T., Luchko, T., Ludueña, R. F., & Tuszyński, J. A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8003336 · Cited by 75
Blade, K. L., Menick, D. R., & Cabral, F. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.13.2213 · Cited by 75
Microtubules in Apoptosis Induction: Are They Necessary?
Braguer, D., Carre, M., & Estève, M. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907783220480 · Cited by 70
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β‐tubulin
Katsetos, C. D., Dráberová, E., Legido, A., Dumontet, C., & Dráber, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21870 · Cited by 68
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Verrills, N. M., & Kavallaris, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764706 · Cited by 65
Self-citationAlterations in γ-Actin and Tubulin-Targeted Drug Resistance in Childhood Leukemia
Verrills, N. M., Po’uha, S. T., Liu, M. L. M., Liaw, T. Y. E., Larsen, M. R., Ivery, M. T. G., Marshall, G. M., Gunning, P. W., & Kavallaris, M. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj372 · Cited by 63
Self-citationPo’uha, S. T., Shum, M., Goebel, A., Bernard, O., & Kavallaris, M. (2009) · Oncogene · doi:10.1038/onc.2009.367 · Cited by 62
Self-citationGan, P. P., & Kavallaris, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1501 · Cited by 59
Self-citationHodgkinson, J. E., Clark, H. J., Kaplan, R. M., Lake, S. L., & Matthews, J. B. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.02.001 · Cited by 58
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. γ‐tubulin
Katsetos, C. D., Dráberová, E., Legido, A., & Dráber, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21884 · Cited by 53
Akasaka, K., Maesawa, C., Shibazaki, M., Maeda, F., Takahashi, K., Akasaka, T., & Masuda, T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.406 · Cited by 52
Sumi, T., Hashigasako, A., Matsumoto, K., & Nakamura, T. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.030 · Cited by 51
Caracciolo, V., D’Agostino, L., Dráberová, E., Sládková, V., Crozier‐Fitzgerald, C., Agamanolis, D. P., de Chadarévian, J., Legido, A., Giordano, A., Dráber, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22077 · Cited by 50
Tau expression and efficacy of paclitaxel treatment in metastatic breast cancer
Tanaka, S., Nohara, T., Iwamoto, M., Sumiyoshi, K., Kimura, K., Takahashi, Y., & Tanigawa, N. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0877-5 · Cited by 49
Huinink, W. W. T. B., Šufliarský, J., Smit, W. M., Spanik, S., Wagnerová, M., Hirte, H. W., Kaye, S. B., Johri, A. R., & Oza, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4826 · Cited by 48
Acute and chronic in vivo therapeutic resistance
Teicher, B. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.006 · Cited by 40
Stathmin/Op18 is a novel mediator of vinblastine activity
Devred, F., Tsvetkov, P. O., Barbier, P., Allegro, D., Horwitz, S. B., Makarov, A. А., & Peyrot, V. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.035 · Cited by 33
Liu, B. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i6.855 · Cited by 30
Melanoma cell sensitivity to Docetaxel‐induced apoptosis is determined by class III β‐tubulin levels
Mhaidat, N. M., Thorne, R. F., de Bock, C. E., Zhang, X. D., & Hersey, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.12.014 · Cited by 27
Bash-Babula, J., Toppmeyer, D., Labassi, M., Reidy, J., Orlick, M., Senzon, R., Alli, E., Kearney, T. J., August, D. A., Shih, W., et al. (2002) · PubMed · Cited by 25
Cited by
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
Polymer nanogels: A versatile nanoscopic drug delivery platform
Chacko, R. T., Ventura, J., Zhuang, J., & Thayumanavan, S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.02.002 · Cited by 645
Keri, R. S., Patil, M. R., Patil, S. A., & Budagumpi, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.059 · Cited by 631
Trastuzumab emtansine: mechanisms of action and drug resistance
Barok, M., Joensuu, H., & Isola, J. (2014) · Breast Cancer Research · doi:10.1186/bcr3621 · Cited by 595
Movers and shakers: cell cytoskeleton in cancer metastasis
Fife, C. M., McCarroll, J. A., & Kavallaris, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12704 · Cited by 551
Self-citation
Metadata
- Authors
- Kavallaris, M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-02-11
- Volume
- 10
- Issue
- 3
- Pages
- 194-204
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2048454522
- Cited by
- 1,120
- References
- 98
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.